Etiometry Co-Authors Award-Winning PCICS Abstract
News and Press Releases
Receives a Prestigious “Top Abstract” Award at the Pediatric Cardiac Intensive Care Society (PCICS) International Meeting
Miami, December 12, 2016—Etiometry, a pioneering leader in next-generation patient monitoring, received a “Top Abstract” award at the PCICS International Meeting for, “Using a High-Fidelity Physiologic Monitoring System to Evaluate a Clinical Protocol for Post-Operative Single Ventricle Congenital Heart Disease.”
The abstract illustrates the tremendous value that high-fidelity data capture brings to the evaluation of the effectiveness of clinical guidelines. It summarizes the results of a joint study between a major Boston pediatric hospital and Etiometry that evaluated the use of the FDA-cleared Etiometry T3 Visualization & Data Aggregation Software to track and record a patient’s physiological state for the purpose of assessing compliance to a clinical protocol as it relates to outcomes.
According to Etiometry COO Evan Butler, “This work demonstrates that the high-frequency, high-fidelity data capture in our T3 Software allows for novel analysis of clinical protocols. It shows how the Etiometry Platform provides unique insight into the effect of guidelines on clinical practice by capturing objective and clear evidence of how patient management is affected by introducing a new standard of care.”
The lead author was Dr. Michael Goldsmith, a pediatric cardiology Fellow at Boston Children’s Hospital, and it was co-authored by Boston Children’s Hospital Pediatric Cardiac Intensivists Dr. Joshua Salvin and Dr. John Kheir and Etiometry’s COO Evan Butler and CTO Dimitar Baronov, PhD.About PCICS
The Pediatric Cardiac Intensive Care Society (PCICS) promotes excellence in pediatric cardiac care medicine. For more information, visit www.pcics.org.About Etiometry
Etiometry Inc. is the leader in clinical decision-support software for the intensive care environment. Our technologies provide valuable clinical insight and analysis to support early recognition of subtle changes in patient condition to avoid complications and speed recovery. Etiometry is committed to improving patient outcomes, increasing clinical efficiency, and lowering costs of care through the more effective use of all available data.
For more information, visit www.etiometry.com.
We’d love to hear from you
Whether you’re curious about how Etiometry can help support your team, the platform’s latest outcomes data or a demo – we’re ready to answer your questions.
Contact UsRelated
PAS 2026 Abstract Reports Association Between IVCO2 Index Implementation and Blood Gas Measurement Frequency in NICU Patients
Boston, Mass., April 27, 2026 – Etiometry announced that a retrospective analysis was presented at the Pediatric Academic Societies (PAS) 2026 Meeting, evaluating changes in blood gas measurement frequency following clinical adoption of its IVCO2 Index in a Level IV Neonatal Intensive Care Unit (NICU). Investigators compared outcomes before and after implementation and reported 10% […]
First FDA-Cleared System Provides Real-Time Data for Cardiogenic Shock
Etiometry was recently featured in a Medscape interview with insights from our co-founder and CTO, Dimitar Baronov, alongside clinicians Walter Schiffer, MD, Cardiologist at Washington University School of Medicine and Srihari Naidu, MD, President of SCAI. The article highlights the importance of early identification in cardiogenic shock and how integrating continuous physiologic data with EHR, […]
Etiometry has been named one of the “Top Most Influential Companies to Watch 2026” by BizTech Outlook.
With recent FDA clearance for the first and only Hospital-Specific Cardiogenic Shock Classification and Tracking tool, we’re expanding how care teams can identify risk earlier and intervene with greater precision. The article highlights how critical care is evolving, using continuous data to help clinicians spot changes sooner and make more informed decisions at the bedside. […]